NO20022044L - 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasöytiske preparater derav og deres anvendelse som antikonvulsive midler - Google Patents

1-(syklisk amino)-alkylsykloheksanforbindelser, farmasöytiske preparater derav og deres anvendelse som antikonvulsive midler

Info

Publication number
NO20022044L
NO20022044L NO20022044A NO20022044A NO20022044L NO 20022044 L NO20022044 L NO 20022044L NO 20022044 A NO20022044 A NO 20022044A NO 20022044 A NO20022044 A NO 20022044A NO 20022044 L NO20022044 L NO 20022044L
Authority
NO
Norway
Prior art keywords
cyclic amino
compounds
pharmaceutical compositions
alleviation
alkyl
Prior art date
Application number
NO20022044A
Other languages
English (en)
Other versions
NO322359B1 (no
NO20022044D0 (no
Inventor
Markus Gold
Wojciech Danysz
Christopher Graham Rap Parsons
Ivars Kalvinsh
Valerjans Kauss
Aigars Jirgensons
Original Assignee
Merz Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharmaceuticals Gmbh filed Critical Merz Pharmaceuticals Gmbh
Publication of NO20022044D0 publication Critical patent/NO20022044D0/no
Publication of NO20022044L publication Critical patent/NO20022044L/no
Publication of NO322359B1 publication Critical patent/NO322359B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022044A 1999-11-01 2002-04-30 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler NO322359B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/008317 WO2001032640A1 (en) 1999-11-01 1999-11-01 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants

Publications (3)

Publication Number Publication Date
NO20022044D0 NO20022044D0 (no) 2002-04-30
NO20022044L true NO20022044L (no) 2002-04-30
NO322359B1 NO322359B1 (no) 2006-09-18

Family

ID=8167482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022044A NO322359B1 (no) 1999-11-01 2002-04-30 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler

Country Status (24)

Country Link
EP (1) EP1228052B1 (no)
JP (1) JP4043236B2 (no)
KR (1) KR100548600B1 (no)
CN (1) CN1264827C (no)
AT (1) ATE361284T1 (no)
AU (1) AU782760B2 (no)
CA (1) CA2389325C (no)
CY (1) CY1106672T1 (no)
CZ (1) CZ20021533A3 (no)
DE (1) DE69936004T2 (no)
DK (1) DK1228052T3 (no)
EA (1) EA005684B1 (no)
ES (1) ES2285870T3 (no)
HK (1) HK1049160B (no)
HU (1) HUP0203275A3 (no)
IL (2) IL149401A0 (no)
MX (1) MXPA02004368A (no)
NO (1) NO322359B1 (no)
PL (1) PL199587B1 (no)
PT (1) PT1228052E (no)
SI (1) SI1228052T1 (no)
TW (1) TWI242547B (no)
UA (1) UA72558C2 (no)
WO (1) WO2001032640A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
SI2091948T1 (sl) 2006-11-30 2012-07-31 Probiodrug Ag Novi inhibitorji glutaminil ciklaze
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
ES2548913T3 (es) 2009-09-11 2015-10-21 Probiodrug Ag Derivados heterocíclicos como inhibidores de glutaminil ciclasa
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
CN104211663B (zh) * 2014-08-11 2017-01-11 杭州偶联医药科技有限公司 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase
RU2714135C1 (ru) * 2019-11-22 2020-02-12 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097207A (en) * 1958-03-06 1963-07-09 Parke Davis & Co 1-halophenyl and 1-alkoxyphenyl cyclohexylamines
EA002254B1 (ru) * 1997-06-30 2002-02-28 Мерц + Ко. Гмбх Унд Ко. 1-аминоалкилциклогексановые антагонисты рецепторов nmda

Also Published As

Publication number Publication date
CA2389325A1 (en) 2001-05-10
UA72558C2 (uk) 2005-03-15
EA005684B1 (ru) 2005-04-28
PL199587B1 (pl) 2008-10-31
CN1264827C (zh) 2006-07-19
KR100548600B1 (ko) 2006-02-01
EA200200522A1 (ru) 2002-10-31
CN1374956A (zh) 2002-10-16
HK1049160A1 (en) 2003-05-02
HUP0203275A2 (hu) 2003-01-28
DE69936004D1 (de) 2007-06-14
EP1228052A1 (en) 2002-08-07
AU1158500A (en) 2001-05-14
CZ20021533A3 (cs) 2002-08-14
PT1228052E (pt) 2007-05-31
PL354519A1 (en) 2004-01-26
HUP0203275A3 (en) 2003-11-28
DK1228052T3 (da) 2007-06-18
ATE361284T1 (de) 2007-05-15
DE69936004T2 (de) 2008-01-10
JP2003513083A (ja) 2003-04-08
NO322359B1 (no) 2006-09-18
WO2001032640A1 (en) 2001-05-10
MXPA02004368A (es) 2002-11-14
IL149401A (en) 2008-03-20
IL149401A0 (en) 2002-11-10
ES2285870T3 (es) 2007-11-16
HK1049160B (zh) 2006-11-17
NO20022044D0 (no) 2002-04-30
SI1228052T1 (sl) 2007-10-31
KR20020063172A (ko) 2002-08-01
JP4043236B2 (ja) 2008-02-06
TWI242547B (en) 2005-11-01
EP1228052B1 (en) 2007-05-02
CY1106672T1 (el) 2012-05-23
CA2389325C (en) 2007-01-09
AU782760B2 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
CY1106672T1 (el) Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα
SE0302760D0 (sv) New compounds
EP1361220A4 (en) CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM
NO980817D0 (no) Meta-guanidin-, urea-, tiourea- eller azacykliske aminobenzosyrederivater som integrin-antagonister
ITMI922006A1 (it) Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
JO2646B1 (en) New differentiated cyclic compounds as beta - lactam inhibitors
ATE297203T1 (de) Antithrombotische mitteln
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
CA2360360A1 (en) Piperidyl benzamide compounds, composition containing same and their use thereof
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
CA2336412A1 (en) Medicament for treatment of diabetes
EA200400140A1 (ru) Пероральные противодиабетические агенты
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
NO973652L (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist
HUP0101701A2 (hu) Szubsztituált béta-alaninok és ezeket tartalmazó gyógyszerkészítmények
ATE240306T1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
CA2226886A1 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
EE05085B1 (et) Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
HUP0104994A2 (hu) Szubsztituált (amino-imino-metil- vagy amino-metil)-benzo-heteroaril-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA05005340A (es) Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
EP1559707A4 (en) SPIRO COMPOUNDS, MEDICINAL COMPOSITIONS CONTAINING THE SAID COMPOUNDS AND INTERMEDIATES THEREOF
CA2335394A1 (en) Aerothricin analogs, their preparation and use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees